WA
PPBT

WuXi AppTec’s Purple Biotech PPBT Stock Holding History

WuXi AppTec’s Portfolio PPBT Stock Details PPBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-971
Closed -$151K – 4
2023
Q4 		$151K Buy
+971
New +$215K 0.39% 4

Other funds holding PPBT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VVP
Venture Visionary Partners Sylvania, Ohio $3.6B AUM 30.03% 1-Year Est. Return
WAOI
Wealth Advisors of Iowa West Des Moines, Iowa $369M AUM 18.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

WuXi AppTec's PPBT Position: Q1 2024 in Review

WuXi AppTec sold out of Purple Biotech (PPBT) in Q1 2024, closing a stake of 971 shares — an estimated $151K sold.

WuXi AppTec first reported a position in PPBT in Q4 2023 and held it in 1 quarter. The position peaked at $151K in Q4 2023. 19 funds tracked by Wall St. Rank hold PPBT as of Q1 2024.

  • WuXi AppTec reported no remaining Purple Biotech position as of Q1 2024 after selling out during the quarter.
  • WuXi AppTec sold 971 Purple Biotech shares in Q1 2024, an estimated $151K.
  • WuXi AppTec first reported a position in Purple Biotech in Q4 2023 and held it in 1 quarter.
  • WuXi AppTec's Purple Biotech position peaked at $151K in Q4 2023.
  • 19 funds tracked by Wall St. Rank held Purple Biotech as of Q1 2024.

Based on WuXi AppTec's 13F filing for Q1 2024, filed 7 May 2024.